All Publications

Pages

1. • Speech

   • 

   A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

   Chiritescu, G Dumon, K Mercadé, T Macarulla Lang, I Vivas, C Santos Papai, Z Janssens, J Hendrickx, K Pracht, M Van den Eynde, Marc[UCL] Taïeb, J Moons, V Geboes, K Van Laethem, J Greil, R Cervantes, A Vergauwe, P Ferrante, M Vanderstraeten, E Fridrik, M Wöll, E Limón, M Rivera, F Sagaert, X Tejpar, S Van Cutsem, E (2018) ESMO 20th World Congress on Gastrointestinal Cancer — (Spain) Barcelona
2. • Journal article

   • 

   The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.

   Van den Eynde, Marc[UCL] Mlecnik, Bernhard Bindea, Gabriela Fredriksen, Tessa Church, Sarah E Lafontaine, Lucie Haicheur, Nacilla Marliot, Florence Angelova, Mihaela Vasaturo, Angela Bruni, Daniela Mourin, Anne[UCL] Baldin, Paméla[UCL] Huyghe, Nicolas[UCL] Haustermans, Karin Debucquoy, Annelies Van Cutsem, Eric Gigot, Jean-François[UCL] Hubert, Catherine[UCL] Kartheuser, Alex[UCL] Remue, Christophe[UCL] Léonard, Daniel[UCL] Valge-Archer, Viia Pagès, Franck Machiels, Jean-Pascal[UCL] Galon, Jérôme (2018) Cancer cell — Vol. 34, no. 6, p. 1012-1026.e3 (2018)
3. • Speech

   • 

   2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial

   Huyghe, Nicolas[UCL] Benidovskaya, Elena[UCL] Masoodi, Tariq Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, M. Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jérôme Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
4. • Speech

   • 

   578P Tissue-resident microbiota characterization in colorectal cancer metastases

   Stevens, Philippe Llorens-Rico, V. Benidovskaya, Elena[UCL] Baldin, Paméla[UCL] Coubeau, Laurent[UCL] Lacroix, valérie Léonard, Daniel[UCL] Bachmann, Radu[UCL] Craciun, Ligia Gofflot, Stéphanie George, Fabienne[UCL] Sandras, Flavienne Sadones, Jan Buys, Magali Raes, Jeroen Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
5. • Speech

   • 

   Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

   Baldin, Paméla[UCL] Beniuga, Gabriella Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Hubert, Catherine[UCL] Navez, Benoît[UCL] Castella, Marie-Laure Van Maanen, Aline[UCL] Mlecnik, Bernhard Galon, Jerome Jouret-Mourin, Anna[UCL] Van den Eynde, Marc[UCL] (2022) 2022 ASCO Annual Meeting I —
6. • Speech

   • 

   Metastatic colorectal cancer has heterogeneous immune microenvironment and mutational expression

   Van den Eynde, Marc[UCL] Mlecnik, Bernhard Bindea, Gabriela Fredriksen, Tessa Lafontaine, Lucie Haicheur, Nacilla Marliot, Florence Debetancourt, Daphné[UCL] Mourin, Anne[UCL] Sempoux, Christine[UCL] Gigot, Jean-François[UCL] Hubert, Catherine[UCL] Kartheuser, Alex[UCL] Remue, Christophe[UCL] Léonard, Daniel[UCL] Carrasco, Javier Humblet, Yves[UCL] Pages, Franck Machiels, Jean-Pascal[UCL] Galon, Jerome (2016) Belgian Week of Gastroenterology - XXVIIIth edition — (Belgium) Bruxelles
7. • Speech

   • 

   Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).

   Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2022) 2022 ASCO Gastrointestinal Cancers Symposium —
8. • Journal article

   • 

   International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

   Pagès, Franck Mlecnik, Bernhard Marliot, Florence Bindea, Gabriela Ou, Fang-Shu Bifulco, Carlo Lugli, Alessandro Zlobec, Inti Rau, Tilman T Berger, Martin D Nagtegaal, Iris D Vink-Börger, Elisa Hartmann, Arndt Geppert, Carol Kolwelter, Julie Merkel, Susanne Grützmann, Robert Van den Eynde, Marc[UCL] Mourin, Anne[UCL] Kartheuser, Alex[UCL] Léonard, Daniel[UCL] Remue, Christophe[UCL] Wang, Julia Y Bavi, Prashant Roehrl, Michael H A Ohashi, Pamela S Nguyen, Linh T Han, SeongJun MacGregor, Heather L Hafezi-Bakhtiari, Sara Wouters, Bradly G Masucci, Giuseppe V Andersson, Emilia K Zavadova, Eva Vocka, Michal Spacek, Jan Petruzelka, Lubos Konopasek, Bohuslav Dundr, Pavel Skalova, Helena Nemejcova, Kristyna Botti, Gerardo Tatangelo, Fabiana Delrio, Paolo Ciliberto, Gennaro Maio, Michele Laghi, Luigi Grizzi, Fabio Fredriksen, Tessa Buttard, Bénédicte Angelova, Mihaela Vasaturo, Angela Maby, Pauline Church, Sarah E Angell, Helen K Lafontaine, Lucie Bruni, Daniela El Sissy, Carine Haicheur, Nacilla Kirilovsky, Amos Berger, Anne Lagorce, Christine Meyers, Jeffrey P Paustian, Christopher Feng, Zipei Ballesteros-Merino, Carmen Dijkstra, Jeroen van de Water, Carlijn van Lent-van Vliet, Shannon Knijn, Nikki Mușină, Ana-Maria Scripcariu, Dragos-Viorel Popivanova, Boryana Xu, Mingli Fujita, Tomonobu Hazama, Shoichi Suzuki, Nobuaki Nagano, Hiroaki Okuno, Kiyotaka Torigoe, Toshihiko Sato, Noriyuki Furuhata, Tomohisa Takemasa, Ichiro Itoh, Kyogo Patel, Prabhu S Vora, Hemangini H Shah, Birva Patel, Jayendrakumar B Rajvik, Kruti N Pandya, Shashank J Shukla, Shilin N Wang, Yili Zhang, Guanjun Kawakami, Yutaka Marincola, Francesco M Ascierto, Paolo A Sargent, Daniel J Fox, Bernard A Galon, Jérôme (2018) The Lancet — Vol. 391, no. 10135, p. 2128-2139 (2018)
9. • Speech

   • 

   Preop chemosensitivity testing as predictor of adjuvant benefit in stage III colon cancer (PEPITA)

   Hendlisz, Alain Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stéphane Clausse, Marylene Vermeij, Joanna D'Hondt, Lionel[UCL] Laurent, Stéphanie Efira, André Peeters, Marc Gomez Galdon, Maria Buggenhout , Alexis Paesmans, Marianne Garcia, Camilo Piccart-Gebhart, Martine J Flamen, Patrick (2014) Belgian Week of Gastroenterology - XXVIth Edition — (Belgium) La Hulpe
10. • Journal article

    • 

    The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis.

    Repullo, Deborah J Barbois, Sandrine[UCL] Léonard, Daniel[UCL] Bohlok, Ali Van den Audenaeren, Estelle T Hendlisz, Alain Van den Eynde, Marc[UCL] Donckier, Vincent Kartheuser, Alex[UCL] Liberale, Gabriel (2021) European Journal of Surgical Oncology — Vol. 47, no. 7, p. 1661-1667 (2021)
11. • Speech

    • 

    Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves respectability but does not achieve patients cure

    Ouaissi, Mehdi Hubert, Catherine[UCL] Dili, Alexandra[UCL] Glineur, David[UCL] Astarci, Parla[UCL] Verhelst, Robert[UCL] Sempoux, Christine[UCL] Deprez, Pierre Henri[UCL] Borbath, Ivan[UCL] Annet, Laurence[UCL] Humblet, Yves[UCL] Van den Eynde, Marc[UCL] Scalliet, Pierre[UCL] Goffette, Pierre[UCL] Loundou, A. Gigot, Jean-François[UCL] (2010) Belgian Week of Gastroenterology - XXIInd Edition — (Belgium) Antwerp
12. • Journal article

    • 

    Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.

    Tabernero, Josep Yoshino, Takayuki Cohn, Allen Lee Obermannova, Radka Bodoky, Gyorgy Garcia-Carbonero, Rocio Ciuleanu, Tudor-Eliade Portnoy, David C Van Cutsem, Eric Grothey, Axel Prausová, Jana Garcia-Alfonso, Pilar Yamazaki, Kentaro Clingan, Philip R Lonardi, Sara Kim, Tae Won Simms, Lorinda Chang, Shao-Chun Nasroulah, Federico RAISE Study Investigators Van den Eynde, Marc[UCL] Humblet, Yves[UCL] (2015) The Lancet Oncology — Vol. 16, p. 499-508 (2015)
13. • Journal article

    • 

    Circulating DNA in the neoadjuvant setting of early stage colon cancer.

    Bregni, Giacomo Pretta, Andrea Senti, Chiara Acedo Reina, Elena Vandeputte, Caroline Trevisi, Elena Gkolfakis, Paraskevas Kehagias, Pashalina Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Peeters, Marc D'Hondt, Lionel[UCL] Geboes, Karen Besse-Hammer, Tatiana Rothé, Françoise Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2022) Acta oncologica — Vol. 61, no. 10, p. 1223-1229 (2022)
14. • Speech

    • 

    394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

    Aparicio, T. Bouche, O. Etienne, P.L. Barbier, E. Mineur, L. Desgrippes, R. Hocine, F. Martin, J.J. Lebrun-Ly, V. Crétin, J. Desrame, J. Rinaldi, Y. Cany, L. Falandry, C. Terrebonne, E. Mosser, L. Pauwels, M. Turpin, A. Van den Eynde, Marc[UCL] Hiret, S. (2021) —
15. • Speech

    • 

    O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study

    Mlecnik, B. Bifulco, C. Marliot, F. Lugli, A. Nagtegaal, I. Hartmann, A. Van den Eynde, Marc[UCL] Roehrl, M. Ohashi, P. Zavadova, E. Torigoe, T. Patel, P. Wang, Y. Kawakami, Y. Hermitte, F. Marincola, F. Ascierto, P. Fox, B. Pagès, F. Galon, J. (2020) ESMO 22nd World Congress on Gastrointestinal Cancer, 2020 Virtual - 1 - 4 July 2020 —
16. • Speech

    • 

    LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer

    Grothey, A. Tabernero, J. Taieb, J. Yaeger, R. Yoshino, T. Maiello, E. Fernandez, E. Elez Casado, A. Ruiz Ross, P. André, T. Kato, T. Ruffinelli, J. Graham, J. Van den Eynde, Marc[UCL] Vera, R. Jean, B. Roussel, E. Carriere Cahuzac, C. Issiakhem, Z. Vedovato, J. Cutsem, E. Van (2020) —
17. • Journal article

    • 

    Cone-beam computed tomography-guided online-adaptive radiotherapy for inoperable right colon cancer: First in human.

    Pierrard, Julien[UCL] Dumont, Damien[UCL] Dechambre, David[UCL] Van den Eynde, Marc[UCL] De Cuyper, Astrid[UCL] Van Ooteghem, Geneviève[UCL] (2023) Technical innovations & patient support in radiation oncology — Vol. 28, p. 100220 [1-5] (2023)
18. • Journal article

    • 

    Evolution of Metastases in Space and Time under Immune Selection.

    Angelova, Mihaela Mlecnik, Bernhard Vasaturo, Angela Bindea, Gabriela Fredriksen, Tessa Lafontaine, Lucie Buttard, Bénédicte Morgand, Erwan Bruni, Daniela Mourin, Anne[UCL] Hubert, Catherine[UCL] Kartheuser, Alex[UCL] Humblet, Yves[UCL] Ceccarelli, Michele Syed, Najeeb Marincola, Francesco M Bedognetti, Davide Van den Eynde, Marc[UCL] Galon, Jérôme (2018) Cell — Vol. 175, no.3, p. 751-765.e16 (2018)
19. • Journal article

    • 

    Celyad's novel CAR T-cell therapy for solid malignancies.

    Lonez, Caroline Hendlisz, Alain Shaza, Leila Aftimos, Philippe Vouche, Michaël Donckier, Vincent Machiels, Jean-Pascal[UCL] Van den Eynde, Marc[UCL] Canon, Jean-Luc Carrasco, Javier Odunsi, Kunle Sahebjam, Solmaz Rottey, Sylvie Braun, Nathalie Verma, Bikash Gilham, David E Lehmann, Frédéric F (2018) Current research in translational medicine — Vol. 66, no.2, p. 53-56 (2018)
20. • Journal article

    • 

    Splenic infarction and bevacizumab.

    Malka, David Van den Eynde, Marc[UCL] Boige, Valérie Dromain, Clarisse Ducreux, Michel (2006) The Lancet Oncology — Vol. 7, p. 1038 (2006)
21. • Speech

    • 

    Impact of primary tumour location (PTL) on outcomes in patients (pts) with metastatic colorectal cancer (mCRC) undergoing first-line panitumumab (Pmab) + FOLFIRI treatment

    Karthaus, Meinolf Van den Eynde, Marc[UCL] Mineur, Laurent Thaler, Josef Koukakis, Reija Berkhout, Marloes Gallego, Javier (2018) The 2018 Gastrointestinal Cancers Symposium — (United States) San Francisco, CA
22. • Journal article

    • 

    Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Fuchs, Charles S Shitara, Kohei Di Bartolomeo, Maria Lonardi, Sara Al-Batran, Salah-Eddin Van Cutsem, Eric Ilson, David H Alsina, Maria Chau, Ian Lacy, Jill Ducreux, Michel Mendez, Guillermo Ariel Alavez, Alejandro Molina Takahari, Daisuke Mansoor, Wasat Enzinger, Peter C Gorbounova, Vera Wainberg, Zev A Hegewisch-Becker, Susanna Ferry, David Lin, Ji Carlesi, Roberto Das, Mayukh Shah, Manish A RAINFALL Study Group Van den Eynde, Marc[UCL] (2019) The Lancet. Oncology — , p. [1-16] (2019)
23. • Speech

    • 

    1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

    Van den Eynde, Marc[UCL] (2022) ESMO Congress 2022, 9 - 13 September 2022 —
24. • Speech

    • 

    449P Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial)

    Baldin, Paméla[UCL] Beniuga, G. Mourin, Anne[UCL] Demolin, G. Roland, S. D'Hondt, L.A. Vergauwe, P. Vandaele, D. Mailleux, M. Sinapi, I.[UCL] De Cuyper, Astrid[UCL] Bletard, N. Massart, B. Delos, M. Castella, M-L. van Maanen, A.[UCL] Carrasco, J. Van den Eynde, Marc[UCL] (2020) ESMO World Congress on Gastrointestinal Cancer —
25. • Speech

    • 

    79O Clinical performance of Immunoscore® in early colon cancer in the Asian population

    Galon, J. Kawakami, Y. Torigoe, T. Wang, Y. Patel, P.S. Vora, H. Mlecnik, B. Marliot, F. Bifulco, C.B. Lugli, A. Nagtegaal, I.D. Hartmann, A. Van den Eynde, Marc[UCL] Roehrl, M.H.A. Ohashi, P.S. Zavadova, E. Marincola, F. Ascierto, P.A. Fox, B.A. Pagès, F. (2020) ESMO World Congress on Gastrointestinal Cancer - GASTROINTESTINAL TUMOURS, COLORECTAL —

Pages